The global enzyme replacement therapy market is witnessing growth as enzyme-based treatments remain an important therapeutic approach for managing certain rare and inherited disorders. The market was valued at US$ 9,673.39 million in 2021 and is projected to reach US$ 15,184.70 million by 2028. The market is estimated to grow at a compound annual growth rate of 6.8% from 2022 to 2028,...
The Global Genomics Market is experiencing substantial growth as advances in genetic research, sequencing technologies, and molecular diagnostics transform healthcare and life sciences. Genomics involves the study of an organism’s complete DNA, including the interactions and functions of genes. Its applications span disease diagnosis, personalized medicine, drug discovery, agricultural...
The global Cell and Gene Therapy Market is expanding as pharmaceutical and biotechnology companies increase their focus on advanced treatments for chronic diseases, genetic disorders, oncology, rare diseases, and personalized medicine. Increasing research activity, biotechnology investments, regulatory support, and technological innovation are contributing to the development and adoption of...
The global Gene Therapy Market is witnessing strong expansion as advancements in genetic engineering, growing prevalence of genetic and chronic diseases, supportive regulatory frameworks, and increasing research and development investments strengthen the adoption of gene therapy solutions. The Gene Therapy Market was valued at US$ 5.06 billion in 2024 and is projected to reach US$ 12.92 billion...
The global enzyme replacement therapy market is witnessing steady growth, driven by the rising prevalence of lysosomal storage diseases and increasing regulatory approvals for treatments targeting rare disorders. The enzyme replacement therapy market is expected to grow from US$ 9,673.39 million in 2021 to US$ 15,184.70 million by 2028. The market is estimated to register a compound annual...
The Global Specialty Pharmaceuticals Market size is projected to reach US$ 2,334.45 billion by 2034 from US$ 293.84 billion in 2025. The market is anticipated to register a CAGR of 25.90% during the forecast period 2026–2034. The growing prevalence of chronic and rare diseases, increasing demand for advanced biologic therapies, rising investments in pharmaceutical research and...
Sickle cell disease is a hereditary blood disorder characterized by the production of abnormal hemoglobin, leading to distorted red blood cells that can obstruct blood flow and cause severe complications. The condition affects millions of individuals globally and often requires lifelong management. Growing awareness of genetic disorders, advancements in treatment options, and increasing...
The Bioinformatics industry in North America is witnessing steady growth as pharmaceutical companies and academic institutions invest heavily in data-driven drug discovery and precision medicine.
The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.
Key Factors Driving...
The Esoteric Testing Market is experiencing significant growth due to the increasing demand for specialized diagnostic testing, rising prevalence of complex diseases, and advancements in molecular diagnostics and laboratory technologies. The global esoteric testing market size is projected to reach US$ 61.11 billion by 2034, up from US$ 25.55 billion in 2025. The market is anticipated to...
In Silico Trials continue to transform global healthcare standards by establishing a safer, faster, and computationally driven model for future medical research and drug commercialization.
The in silico trials market size is expected to reach US$ 12.75 billion by 2034 from US$ 4.64 billion in 2025. The market is anticipated to register a CAGR of 11.9% during 2026–2034.
What is driving...
Clinical Precision and Targeted Theranostics: Global Nuclear Medicine Market Set to Reach USD 18.87 Billion by 2030
Maximize Market Research, a global market intelligence, sector forecasting, and executive consulting powerhouse, has published a comprehensive industry analysis of the Global Nuclear Medicine Market. Valued at USD 7.22 Billion in 2023, the global nuclear medicine sector is on an...
The North America Bioinformatics Platforms sector is expanding with increasing investment in genomics, biotechnology, precision medicine, and pharmaceutical research. Advanced computational infrastructure and strong R&D capabilities are supporting adoption.
The global bioinformatics platforms market size is projected to reach US$ 1,619.51 million by 2034 from US$ 644.19 million in...